Literature DB >> 8412096

Endothelins mediate intestinal hypoperfusion during bacteremia.

M A Wilson1, G D Steeb, R N Garrison.   

Abstract

We have previously reported that Escherichia coli bacteremia induces hypoperfusion and vasoconstriction of the rat small intestinal microcirculation. However, the mechanisms which mediate these responses are not clearly defined. Because serum levels of endothelins, a family of potent vasoconstrictor peptides, are increased during bacteremia, we postulated that endothelins contribute to intestinal hypoperfusion during infection. Using intravital microscopy, we characterized the effects of topically applied recombinant endothelin-1 on small intestinal arteriolar diameters and blood flow. Dose-dependent vasoconstriction of both large (A1) and small (A3) arterioles and hypoperfusion were observed. To assess whether endothelins contribute to alterations of the intestinal microcirculation during bacteremia, antiserum was used to inhibit endothelins during E. coli bacteremia. Endothelin inhibition resulted in restoration of blood flow and attenuation of vasoconstriction. Our results suggest that endothelins contribute to intestinal hypoperfusion and arteriolar vasoconstriction during bacteremia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8412096     DOI: 10.1006/jsre.1993.1125

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

Review 1.  Endothelin-1 and its role in the pathogenesis of infectious diseases.

Authors:  Brandi D Freeman; Fabiana S Machado; Herbert B Tanowitz; Mahalia S Desruisseaux
Journal:  Life Sci       Date:  2014-04-26       Impact factor: 5.037

2.  Differentiated effects on splanchnic homeostasis by selective and non-selective endothelin receptor antagonism in porcine endotoxaemia.

Authors:  A Oldner; M Wanecek; E Weitzberg; P Sundin; A Sollevi; C Rubio; P M Hellström; K Alving; A Rudehill
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

3.  Haemodynamic effects of endothelin receptor antagonist, tezosentan, in tumour necrosis factor-alpha treated anaesthetized rats.

Authors:  Reza Tabrizchi; Carol Ann Ford
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-01-18       Impact factor: 3.000

4.  Granulocyte-macrophage colony-stimulating factor and interleukin-3 potentiate interferon-gamma-mediated endothelin production by human monocytes: role of protein kinase C.

Authors:  B Salh; K Hoeflick; W Kwan; S Pelech
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

5.  The endothelin receptor antagonist bosentan restores gut oxygen delivery and reverses intestinal mucosal acidosis in porcine endotoxin shock.

Authors:  A Oldner; M Wanecek; M Goiny; E Weitzberg; A Rudehill; K Alving; A Sollevi
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

6.  Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat.

Authors:  H Ruetten; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

7.  Association of endothelin genetic variants and hospitalized infection complications in end-stage renal disease (ESRD) patients.

Authors:  Chih-Chin Kao; Shih-Ying Cheng; Yu-Jia Wang; Shu-Chen Chien; Yu-Wen Hsu; Mei-Yi Wu; Hsing-Fang Lu; Sean Nam; Tao Sun; Mai-Szu Wu; Wei-Chiao Chang
Journal:  BMC Nephrol       Date:  2019-06-05       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.